Skip to main content
S&P 5007,818.93+0.58%DOW51,521.28+0.49%NASDAQ27,599.89+0.45%BTC$85,520.00-0.35%ETH$2,697.04-0.63%GOLD$4,189.90+0.07%OIL$89.91+0.53%
Smart Investors Daily
SID Premium
AD

NASDAQ · ADIL

Adial Pharmaceuticals, Inc.

Healthcare · Biotechnology

$4.35

Down-$0.37 (-8.51%)

Updated Oct 7, 2026, 1:51 AM

SID Score

3.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2.43M
P/E ratio
-0.28
Dividend yield
0.00%
52-week range
$1.31 – $10.75
Volume
60.03K
Avg. volume
28.85K

Price performance · ADIL

ADIL price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 5, 2026

ADIL closed at $4.35 after 20 trading sessions, down 34.59% for the selected period.

Last close
$4.35
Period change
-34.59%
Period low
$4.01
Period high
$6.65
Daily close
View OHLC price history
ADIL OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 5, 2026$4.05$4.425$3.92$4.3560.03K
Oct 2, 2026$4.13$4.66$3.92$4.1264.5K
Oct 1, 2026$4.12$4.45$3.86$4.1313.39K
Sep 30, 2026$4.155$4.29$3.95$4.0135.32K
Sep 29, 2026$4.04$4.30$3.97$4.1529.32K
Sep 28, 2026$4.05$4.2992$3.85$4.0447.49K
Sep 25, 2026$4.40$4.56$4.12$4.2233.17K
Sep 24, 2026$4.00$4.64$4.00$4.4447.38K
Sep 23, 2026$4.25$4.25$3.77$4.0460.94K
Sep 22, 2026$4.40$4.42$4.14$4.2040.21K
Sep 21, 2026$4.82$4.82$4.23$4.4043.69K
Sep 18, 2026$5.23$5.23$4.59$4.8686.98K
Sep 17, 2026$5.25$5.38$5.04$5.2121.63K
Sep 16, 2026$5.01$5.30$5.00$5.2429.68K
Sep 15, 2026$5.02$5.18$4.80$5.0029.01K
Sep 14, 2026$4.94$5.18$4.87$5.0046.52K
Sep 11, 2026$6.06$6.11$4.80$4.90108.48K
Sep 10, 2026$5.94$6.22$5.90$5.99517.27K
Sep 9, 2026$6.64$6.65$5.87$5.9348.67K
Sep 8, 2026$7.01$7.20$6.33$6.6567.62K

Latest ADIL news

The latest Smart Investors Daily articles mentioning ADIL.

Stock researchCompany · Overview

ADIL research

Overview

Company profile and research snapshot.

Company profile

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
ADIL recent ratings
DateFirmRatingTarget
Aug 3, 2026Alliance Global PartnersBuy—
Jun 15, 2026LUCID CAPITAL MARKETSBuy—
Sep 30, 2025Maxim GroupBuy—
Nov 14, 2024Rodman & RenshawBuy—
Jul 11, 2023Brookline CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 30, 2026

Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

GLEN ALLEN, Va., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee has granted a new employee stock option to purchase 155,446 shares of common stock as an inducement to such person becoming an employee of the Company. The option award has an exercise price of $4.22 per share, the closing price of the Company’s common stock on September 25, 2026, the effective date of grant and has a

Yahoo · Aug 25, 2026

Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

GLEN ALLEN, Va., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee has granted a new employee stock option to purchase 307,814 shares of common stock as an inducement to such person becoming an employee of the Company. The option award has an exercise price of $5.76 per share, the closing price of the Company’s common stock on August 19, 2026, the effective date of grant and has a ten-

Benzinga · Aug 24, 2026

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers Innovative Eyewear (NASDAQ:LUCY) stock rose 63.6% to $1.12 during Monday's regular session. The market value of their outstanding shares is at $5.8 million. Picard Medical (AMEX:PMI) shares increased by

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By